BIOMAT Database Logo BIOMAT Database Logo

Variability in absorption of insulin-I 131 in normal and diabetic subjects after subcutaneous and intramuscular injection. 1959

E W MOORE, and M L MITCHELL, and T C CHALMERS

UI MeSH Term Description Entries
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

E W MOORE, and M L MITCHELL, and T C CHALMERS
Absorption of insulin-I-131 from subcutaneous tissue in diabetic patients.
January 1962, The American journal of the medical sciences,
E W MOORE, and M L MITCHELL, and T C CHALMERS
Peritoneal and subcutaneous absorption of insulin in type I diabetic subjects.
September 1993, The Journal of clinical endocrinology and metabolism,
E W MOORE, and M L MITCHELL, and T C CHALMERS
Rate of clearance of insulin labelled with 131 I from the subcutaneous tissues in normal and diabetic subjects.
May 1959, Lancet (London, England),
E W MOORE, and M L MITCHELL, and T C CHALMERS
[THE INTERPRETATION OF THE CURVES OF PLASMATIC RADIOACTIVITY OBTAINED AFTER INTRAVENOUS INJECTION OF I-131 LABELED INSULIN IN NORMAL AND DIABETIC SUBJECTS].
May 1963, Minerva nucleare,
E W MOORE, and M L MITCHELL, and T C CHALMERS
Effect of insulin-induced hypoglycaemia on absorption of unmodified insulin after subcutaneous or intramuscular injection.
January 1991, Diabetic medicine : a journal of the British Diabetic Association,
E W MOORE, and M L MITCHELL, and T C CHALMERS
Salivary immunoreactive insulin in type I diabetic patients after subcutaneous injection of insulin.
January 1986, The Journal of nuclear medicine and allied sciences,
E W MOORE, and M L MITCHELL, and T C CHALMERS
Absorption and miscibility of regular porcine insulin after subcutaneous injection of insulin-treated diabetic patients.
January 1983, Diabetes care,
E W MOORE, and M L MITCHELL, and T C CHALMERS
INSULIN I-131 BINDING IN SERUM FROM NORMAL AND DIABETIC SUBJECTS BY ULTRACENTRIFUGATION AND GEL FILTRATION.
January 1965, Diabetes,
E W MOORE, and M L MITCHELL, and T C CHALMERS
Insulin absorption and subcutaneous blood flow in normal subjects during insulin-induced hypoglycemia.
September 1988, The Journal of clinical endocrinology and metabolism,
E W MOORE, and M L MITCHELL, and T C CHALMERS
Porcine and human insulin absorption from subcutaneous tissues in normal and insulin-dependent diabetic subjects: a deconvolution-based approach.
September 1988, The Journal of clinical endocrinology and metabolism,
Copied contents to your clipboard!